Schedule 13D ownership disclosure
SYROS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 87184Q206
Event date: 2023-01-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,588,564
- Percent of class
- 7.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-110484
- Form type
- SC 13D
- Filer
- Samsara BioCapital, L.P.
- CIK
- CIK 1699737
- Filed
- Oct 20, 2023
- Reporting period
- Jan 15, 2023
- Description
- Schedule 13D beneficial ownership